Skip to main content
Free for a limited time Lung Transplantation Review

Are surveillance biopsies after lung transplantation necessary?

In people undergoing lung transplantation, graft function can be monitored via routinely scheduled surveillance biopsies or via noninvasive assessments. But which approach is best?

Delayed diagnosis of APAP in patient with dermatomyositis

Open Access Respiratory Medicine Case Study

Differentiating autoimmune pulmonary alveolar proteinosis (APAP) from a flare-up of interstitial pneumonia associated with dermatomyositis is challenging. This case highlights the need for early APAP scrutiny.

CAP misdiagnoses increase unnecessary antibiotic use

One in eight hospitalized patients, particularly those with dementia, are inappropriately diagnosed with community-acquired pneumonia.

Oral corticosteroids reduce wheeze severity in preschoolers

11-04-2024 Respiratory Medicine News

Children with preschool wheeze experience a significantly greater reduction in wheeze severity 4 hours after treatment with the oral corticosteroid prednisolone versus placebo.

Interstitial lung abnormalities and pulmonary fibrosis

An overview of the similarities and differences between interstitial lung abnormalities (ILAs) and pulmonary fibrosis, and guidance on the clinical management of people with ILAs.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Live Webinar | 02-05-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on sleep in brain health

Live: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.

Dr. Rolf Fronczek
Dr. Sven Rupprecht
Dr. Renata Riha
Developed by: Springer Medicine

Delayed diagnosis of APAP in patient with dermatomyositis

Open Access Respiratory Medicine Case Study

Differentiating autoimmune pulmonary alveolar proteinosis (APAP) from a flare-up of interstitial pneumonia associated with dermatomyositis is challenging. This case highlights the need for early APAP scrutiny.

Anti-synthetase syndrome with pneumomediastinum in a child

Open Access Respiratory Medicine Case Study

Anti-synthetase syndrome (ASS) is an autoimmune disorder primarily affecting adult women, but this report describes the first case of ASS complicated with pneumomediastinum in a child.

Delivering ECMO despite jugular vein thrombosis

Open Access Venous Thrombosis Case Study

A patient with aspiration pneumonia-induced ARDS required  venovenous ECMO cannulation, but presented with multiple thrombi in the internal jugular veins which limited access. VV-ECMO was alternatively established using the right axillary vein as the access site.

Next-generation sequencing

Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes. 

In this vodcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint. 

Supported by: Illumina, Inc., and Eli Lilly and Company

Prof. Andrew Beggs
Developed by: Springer Healthcare

Current Reviews

Acute lung injury: a view from the perspective of necroptosis

Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common critical illness in the ICU, with an in-hospital mortality rate of 34.9%–46.1%. Approximately 10.4% of ICU patients meet the diagnostic criteria for ARDS, and …

The Physiologically Difficult Airway and Management Considerations

Open Access Difficult Airway Airway Management (LC Berkow, Section Editor)

The physiologically difficult airway was first described as a framework to explain the high rate of morbidity and mortality that occurs in critically ill patients despite one or few attempts, regardless of the presence or absence of any anatomic …

Exploring the role of the human microbiome in forensic identification: opportunities and challenges

Open Access Respiratory Microbiota Review

Forensic microbiology is rapidly emerging as a novel tool for human identification. The human microbiome, comprising diverse microbial communities including fungi, bacteria, protozoa, and viruses, is unique to each individual, offering a new …

Head-to-toe bedside ultrasound for adult patients on extracorporeal membrane oxygenation

ECMO Narrative Review

Bedside ultrasound represents a well-suited diagnostic and monitoring tool for patients on extracorporeal membrane oxygenation (ECMO) who may be too unstable for transport to other hospital areas for diagnostic tests. The role of ultrasound …

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine

Infographic

This expert-led infographic explains how to recognize and manage COPD exacerbations and explores the impact of these exacerbations at the patient and physician level.

Supported by:
  • Sanofi and Regeneron
Developed by: Springer Healthcare

eLearning | Interviews | Digital Treatment Map (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.

Supported by:
  • Bayer HealthCare Pharmaceuticals Inc.
Developed by: Springer Healthcare IME

Digital Treatment Map (Link opens in a new window)

Practical, expert-led digital map designed to guide treatment of ALK- and ROS1-mutation positive NSCLC.

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
NSCLC Podcast

Episode 7: A deep dive into ADAURA

The ADAURA trial has, as of this year, demonstrated an overall survival benefit with the adjuvant use of osimertinib in people with resectable NSCLC. 

We take an in-depth look at the study with Dr. Luis Paz-Ares, who outlines the study findings, discusses the clinical implications, and addresses the pertinent questions raised by the trial.

Dr. Luis Paz-Ares

Editor's Choice | Respiratory Medicine Journals

Further Reading

The Physiologically Difficult Airway and Management Considerations

Open Access Difficult Airway Airway Management (LC Berkow, Section Editor)

The physiologically difficult airway was first described as a framework to explain the high rate of morbidity and mortality that occurs in critically ill patients despite one or few attempts, regardless of the presence or absence of any anatomic …

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

Open Access Osimertinib Original Research

In patients with advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor ( EGFR ) mutations, compared with first-generation EGFR-tyrosine kinase inhibitors (TKIs), the third-generation EGFR-TKI osimertinib is …

Lincosamide monotherapy treatment of methicillin-resistant Staphylococcus aureus pneumonia in tropical Australia: a case series

Open Access Pneumonia Brief Report

Existing recommended first-line antibiotic agents for MRSA pneumonia have several shortcomings. We reviewed 29 cases of community- and hospital-acquired MRSA pneumonia managed at our hospital. Lincosamide monotherapy was administered to 21/29 …

Derivation and validation of a predictive mortality model of in-hospital patients with Acinetobacter baumannii nosocomial infection or colonization

Open Access Non-Invasive Ventilation Original Article

Acinetobacter baumannii (Ab) is a Gram-negative opportunistic bacterium responsible for nosocomial infections or colonizations. At present, it is considered one of the most alarming pathogens due to its multi-drug resistance [ 1 ]. Ab infections …

Related topics

The first case of severe megaloblastic anemia in a patient treated with erlotinib for advanced NSCLC. It highlights the need for close clinical and blood monitoring in people receiving long-term TKI therapy.

Read more